Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials

[1] Gangale M.F.(2011)Longterm metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome Clin Endocrinol (Oxf) 75 520-527

[2] Miele L.(2012)Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome Hum Reprod 27 1439-1444

[3] Lanzone A.(2011)Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study Clin Endocrinol (Oxf) 75 89-96

[4] Kim J.J.(2010)Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2038-2049

[5] Choi Y.M.(2010)Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS J Clin Endocrinol Metab 95 3933-3939

[6] Cho Y.M.(2010)Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study Cancer Causes Control 21 2303-2308

[7] Chang A.Y.(2009)Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS) Contemp Clin Trials 30 451-456

[8] Ayers C.(2003)Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance J Intern Med 254 32-44

[9] Minhajuddin A.(2007)PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J Intern Med 262 184-198

[10] Wild R.A.(2009)Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients J Clin Endocrinol Metab 94 4453-4457

[1] Gangale M.F.(2011)Longterm metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome Clin Endocrinol (Oxf) 75 520-527

[2] Miele L.(2012)Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome Hum Reprod 27 1439-1444

[3] Lanzone A.(2011)Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study Clin Endocrinol (Oxf) 75 89-96

[4] Kim J.J.(2010)Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2038-2049

[5] Choi Y.M.(2010)Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS J Clin Endocrinol Metab 95 3933-3939

[6] Cho Y.M.(2010)Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study Cancer Causes Control 21 2303-2308

[7] Chang A.Y.(2009)Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS) Contemp Clin Trials 30 451-456

[8] Ayers C.(2003)Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance J Intern Med 254 32-44

[9] Minhajuddin A.(2007)PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J Intern Med 262 184-198

[10] Wild R.A.(2009)Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients J Clin Endocrinol Metab 94 4453-4457